|
Status |
Public on Dec 31, 2017 |
Title |
genomic DNA from MCF-7 treated Ginsenoside Rg3 |
Sample type |
genomic |
|
|
Source name |
mammary gland, breast; derived from metastatic site: pleural effusion
|
Organism |
Homo sapiens |
Characteristics |
cell line: MCF-7 cell type: epithelial gender: female disease: adenocarcinoma
|
Extracted molecule |
genomic DNA |
Extraction protocol |
genomic DNA was extracted and purified from MCF-7 using ZR Dyet DNA/RNA kit (Zymo research) according to standard instructions
|
Label |
biotin
|
Label protocol |
Standard Illumina Protocol
|
|
|
Hybridization protocol |
bisulphite converted DNA was amplified, fragmented and hybridised to Illumina Infinium Human MethylationEPIC 850K Beadchip using standard Illumina protocol
|
Scan protocol |
Standard Illumina procedures using Illumina iScan scanner
|
Description |
SAMPLE 2 breast cancer
|
Data processing |
Background correction, Extraction of CpGs with detection p-value ≥ 0.05 more than 25% of all samples, and BMIQ normalization
|
|
|
Submission date |
May 31, 2017 |
Last update date |
Dec 31, 2017 |
Contact name |
seungyeon lee |
E-mail(s) |
cathylee920930@gmail.com
|
Phone |
+82-10-3345-6681
|
Organization name |
dongguk unversity
|
Department |
life science
|
Lab |
molecular biology
|
Street address |
dongguk-ro 32
|
City |
goyang |
ZIP/Postal code |
10326 |
Country |
South Korea |
|
|
Platform ID |
GPL21145 |
Series (1) |
GSE99505 |
Ginsenoside Rg3 epigenetically regulates cell-mediated immune pathway to inhibit proliferation of the MCF-7 breast cancer cell |
|